Dr Robert Ruffolo joins Trevena's board of directors
This article was originally published in Scrip
Executive Summary
The US specialist GPCR drug discovery company Trevena has announced that Dr Robert Ruffolo has joined its board of directors. He joined the company's scientific advisory board in January. Dr Ruffolo is the retired president of R&D at Wyeth Pharmaceuticals. He also spent 17 years at SmithKline Beecham and six years at Lilly Research Laboratories. Dr Ruffolo won the Lifetime Achievement Award at the 2008 Scrip Awards.